SugaROx Ltd

Verwendung der Mittel

Pilot production and establishment of a pilot facility; scaling of manufacturing processes; expanded field trials; preparation for market launch.

Alle Investoren (3)

• UK Innovation & Science Seed Fund (UKI2S)
• The Mosaic Company
• Regenerate Ventures

Analyse-Artikel

SugaROx sichert 1,1 Mio. € zur Beschleunigung von T6P‑Biostimulant

Artikel lesen